EKSO NASDAQ
Ekso Bionics Holdings, Inc.
1W: -26.7%
1M: +41.5%
3M: +54.7%
YTD: +110.3%
1Y: +253.1%
3Y: -21.5%
5Y: -80.7%
$15.90
Last traded 2026-07-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$51M
Revenue
+248.0% YoY
$-55M
Net Income
-400.4% YoY
$6M
Free Cash Flow
+166.8% YoY
-10.0%
Gross Margin
-63.7%
Op. Margin
-102.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-68.7%
ROA-34.8%
ROIC-12.2%
Valuation
P/E-3.6
P/B15.3
EV/EBITDA-66.5
Leverage
Debt/Equity0.74
Current Ratio0.30
Interest Cov.-5.6x
Quality Scores
Piotroski F3/9
Altman Z8.54
Beneish M10.54